The largest database of trusted experimental protocols

Clindamycin

Manufactured by Cayman Chemical
Sourced in United States, Italy

Clindamycin is a lab equipment product used for research purposes. It is a lincosamide antibiotic that inhibits bacterial protein synthesis. The specific core function of Clindamycin is to serve as a research tool for investigating its antimicrobial properties and potential applications.

Automatically generated - may contain errors

2 protocols using clindamycin

1

Nisin-Guar Gum Biogel with Antibiotics

Check if the same lab product or an alternative is used in the 5 most similar protocols
A stock solution of nisin (1000 μg/mL) was obtained by dissolving 1 g of nisin powder (2.5% purity Sigma-Aldrich, USA) in 25 mL of HCl (0.02 M) (Merck, Germany), filtered using a 0.22 μm cellulose acetate membrane filter and stored at 4°C. The stock solution was then diluted with sterile water to a concentration of 45 μg/mL.
A guar gum gel 1.5% (w/v) was prepared by dissolving 0.6 g of guar gum (Sigma-Aldrich, USA) in 40 mL of sterile distilled water and heat sterilized by autoclave. The solution of nisin was incorporated within the guar gum gel in a proportion of 1:1, obtaining a final 0.75% (w/v) biogel with 22.5 μg/mL of nisin.
Regarding antibiotics solutions, 6.6, 4.76 and 10.62 mg of Clindamycin (Cayman, USA), Gentamicin (PanReac AppliChem, USA) and Vancomycin (PanReac AppliChem, USA), respectively, were dissolved in 10 mL of sterile water and filtered through a 0.22 μm cellulose acetate membrane filter. Stock solutions were kept frozen at -80°C and diluted to the final concentrations of 0.033 μg/mL for Clindamycin, 0.238 μg/mL for Gentamicin and 0.531 μg/mL for Vancomycin, prior to utilization.
+ Open protocol
+ Expand
2

Dual-AMP biogel for antimicrobial treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stock solutions of gentamicin (ITW Reagents, Monza, Italy) were prepared at 4760 µg/mL, clindamycin (Cayman Chemical, Michigan, MI, USA) at 660 µg/mL, and vancomycin (ITW Reagents, Monza, Italy) at 1062 µg/mL, according to the manufacturer’s specifications, and kept at −80 °C. Antibiotic working solutions were used at their minimum inhibitory concentration (MIC) values (gentamicin, 0.238 µg/mL; clindamycin, 0.033 µg/mL; and vancomycin, 0.531 µg/mL), as determined in a previous study [65 (link)].
Nisin A (1000 UI/mg, 2.5% purity) (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in 0.02 M HCl (Merck, Darmstadt, Germany), yielding a 1000 µg/mL stock solution, and pexiganan (>95% purity; Innovagen, Lund, Sweden) was dissolved in deionized sterile water, yielding a 2048 µg/mL stock solution. These solutions were then filtered through a 0.22 µm filter (Millipore Corporation, Billerica, MA, USA) and kept at 4 °C. To prepare the dual-AMP biogel, a pexiganan solution at 256 µg/mL was enriched with Nisin At 125 µg/mL, corresponding to their minimum biofilm eradication concentration (MBEC) values, as determined previously [25 (link)]. 0.75 g of guar gum (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in 50 mL of sterile distilled water, yielding a 1.5% (w/v) gel, which was sterilized by autoclave. Antibiotics and AMPs were mixed into the gel in a 1:1 ratio.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!